Flu Is Relentless. Crispr Might Be Able to Shut It Down
Scientists at Melbourne’s Peter Doherty Institute for Infection and Immunity are working on a Crispr-based treatment – delivered as a nasal spray or injection – that could stop influenza infections by targeting the virus’s RNA and disrupting its ability to replicate inside human cells.

The approach uses the Cas13 enzyme, a lesser-known cousin of the DNA-cuttin … ⌘ Read more